# CLEARLAX

NDC: 70677-1068
Generic name: polyethylene glycol 3350
Labeler / Manufacturer: STRATEGIC SOURCING SERVICES LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SOLUTION
Routes: ORAL
Marketing started: 20230801
Marketing ended: 20261231
FDA application: ANDA090812

## Active ingredients

- POLYETHYLENE GLYCOL 3350: 17 g/17g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70677-1068"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70677-1068
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=041157b8-476c-e7d2-e063-6394a90ac3a0